A retrospective cohort study of dermatofibrosarcoma protuberans at a large metropolitan academic center
Charlotte Greif, BA, Divya Srivastava, MD, Rajiv I. Nijhawan, MD
JAAD International · 2022
doi:10.1016/j.jdin.2021.12.013 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
To the Editor: Dermatofibrosarcoma protuberans (DFSP) is a rare, low-grade dermal mesenchymal malignancy that commonly presents as a slow-growing, asymptomatic nodule.1,2 Although its metastasis is uncommon, the tumor tends to recur locally following incomplete excision.3 The clinicopathologic features associated with poor outcomes include treatment with wide local excision (WLE), compared with that with Mohs micrographic surgery (MMS); positive histologic margins; the presence of a fibrosarcomatous change; age >50 years; a large tumor size (>5 cm); African American ethnicity; male sex; and a location on the head, neck, or extremity rather than on the trunk.
Abstract licence: CC BY-NC-ND
References4
4 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.